Roche obesity drug shows 22.5% weight loss as it seeks to catch up with Lilly, Novo
Roche obesity drug shows 22.5% weight loss in Phase-II trialRoche focuses on catching Lilly in $150 billion obesity…
Zurich Insurance’s property and casualty gross written premiums rise on data center boost
May 13 (Reuters) – Zurich Insurance (ZURN.S), opens new tab reported higher first-quarter gross written premiums for its…
US FDA approves Novartis’ gene therapy for rare muscle disorder
Item 1 of 3 The company’s logo is seen at a building of Swiss drugmaker Novartis in Rotkreuz,…